In deliveryUnited KingdomGoods£70,828,856
Biologic and Biosimilar Medicines
- Published
- Published 17 September 2024
- Deadline
- Closed 18 October 2024
Overview
Biologic and Biosimilar Medicines
Key details
- Country
- United Kingdom
- Status
- In delivery
- Category
- Goods
- Estimated value
- £70,828,856
- Procedure
- Open
- Published
- 17 September 2024
- Deadline
- Closed
Pharmaceutical products
Award outcome
- Awarded value
- £96,642,400
- Award date
- 22 April 2025
- Contract period
- 30 June 2025 → 30 June 2028
- Abbvie Ltd
- Accord-UK Ltd
- Amgen Ltd
- Biogen Idec Limited
- Biosimilar Collaborations Ireland Limited
- Celltrion Healthcare United Kingdom Limited
- Dr Reddy's
- Eli Lilly and Company Limited
- Fresenius Kabi Ltd
- Gedeon Richter (UK) LImited
- Janssen-Cilag Ltd
- Organon Pharmaceuticals UK Ltd
- Pfizer Ltd
- Roche Products Ltd
- Sandoz Ltd
- Sun Pharma UK Ltd
- Teva UK Ltd
- Thornton & Ross Ltd
- Zentiva Pharma UK Limited
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract
21 May 2025
View notice ↗Contract Notice
17 September 2024
View notice ↗
Contracting authority
Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts)
BuyerNewport, United Kingdom
Authority website ↗eTenderwales
BuyerNewport, United Kingdom
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.